共 9 条
[1]
Ahmad S., Lovastatin warfarin interaction, Archives of Internal Medicine, 150, (1990)
[2]
Brers O., Jacobsen S., pH lability in serum during equilibrium dialysis, British Journal of Clinical Pharmacology, 20, pp. 85-88, (1985)
[3]
East C., Alivizatos P.A., Grundy S.M., Jones P.H., Farmer J.A., Rhab-domyolysis in patients receiving lovastatin after cardiac transplantation, New England Journal of Medicine, 318, pp. 47-48, (1988)
[4]
Grundy S.M., HMG-CoA reductase inhibitors for treatment of hypercholesterolemia, New England Journal of Medicine, 319, pp. 24-32, (1988)
[5]
LaRosa J.C., Pravastatin: a new hydrophilic HMG-CoA-reductase inhibitor, New advances in the control of lipid metabolism: focus on pravastatin, pp. 39-43, (1989)
[6]
McTavish D., Sorkin E.M., Pravastatin: a review of its pharmacological properties and therapeutic potential in hyperchol-esterolaemia, Drugs, 42, 1, pp. 65-89, (1991)
[7]
O'Connor P., Feely J., Shepherd J., Lipid lowering drugs, British Medical Journal, 300, pp. 667-672, (1990)
[8]
Pan H.Y., Triscari J., de Vault A.R., Smith S.A., Wang-Iverson D., Et al., Pharmacokinetic interaction between propranolol and the HMG-Co A Reductase inhibitors pravastatin and lovastatin, British Journal of Clinical Pharmacology, 31, pp. 665-670, (1991)
[9]
Todd P.A., Goa K.L., Simvastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia, Drugs, 40, 4, pp. 583-607, (1990)